The Fas Counterattack: A Molecular Mechanism of Tumor Immune Privilege

被引：0
|
作者：
Joe O’Connell
Michael W. Bennett
Gerald C. O’Sullivan
J. Kevin Collins
Fergus Shanahan
机构：
[1] National University of Ireland,Department of Medicine
[2] National University of Ireland,Department of Surgery
[3] University Hospital,Department of Medicine, Clinical Sciences Building
来源：
Molecular Medicine | 1997年 / 3卷
关键词：
Tumor Immune Privilege; FasL Expression; Hematopoietic Cell Protein-tyrosine Phosphatase (HCP); Monocytic Leukemia Cell Line U937; Diverse Cancer Cell Lines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：294 / 300
页数：6
相关论文
共 50 条
  • [31] Fas-Ligand and immune privilege: The eyes have it
    Ferguson, TA
    Green, DR
    CELL DEATH AND DIFFERENTIATION, 2001, 8 (07): : 771 - 772
  • [32] Immune privilege or inflammation? Insights into the Fas ligand enigma
    Joe O'Connell
    Aileen Houston
    Michael W. Bennett
    Gerald C. O'Sullivan
    Fergus Shanahan
    Nature Medicine, 2001, 7 : 271 - 274
  • [33] Fas-Ligand and Immune Privilege: The Eyes Have It
    T A Ferguson
    D R Green
    Cell Death & Differentiation, 2001, 8 : 771 - 772
  • [34] The role of fas ligand and transforming growth factor β in tumor progression -: Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy
    Kim, R
    Emi, M
    Tanabe, K
    Uchida, Y
    Toge, T
    CANCER, 2004, 100 (11) : 2281 - 2291
  • [35] Immune privilege or inflammation? Insights into the Fas ligand enigma
    O'Connell, J
    Houston, A
    Bennett, MW
    O'Sullivan, G
    Shanahan, F
    NATURE MEDICINE, 2001, 7 (03) : 271 - 274
  • [36] Immune escape of tumors: apoptosis resistance and tumor counterattack
    Igney, FH
    Krammer, PH
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 71 (06) : 907 - 920
  • [37] Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape
    Elnemr, A
    Ohta, T
    Yachie, A
    Kayahara, M
    Kitagawa, H
    Ninomiya, I
    Fushida, S
    Fujimura, T
    Nishimura, GI
    Shimizu, K
    Miwa, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (01) : 33 - 39
  • [38] Immune privilege sites require a higher threshold level of membrane Fas ligand to stimulate inflammation and tumor rejection
    Gregory, MS
    Repp, A
    Hohlbaum, A
    Saff, R
    Marshak-Rothstein, A
    Ksander, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U449 - U449
  • [39] Overexpression of Fas ligand does not confer immune privilege to a pancreatic β tumor cell line (βTC-3)
    Okamoto, S
    Takamizawa, S
    Bishop, W
    Wen, J
    Kimura, K
    Sandler, A
    JOURNAL OF SURGICAL RESEARCH, 1999, 84 (01) : 77 - 81
  • [40] A novel mechanism of tumor immune evasion through Fas ligand bearing exosomes
    Ichim, TE
    Wang, XM
    Li, M
    O'Brien, CA
    Zhong, R
    Chin, JL
    Min, WP
    FASEB JOURNAL, 2004, 18 (04): : A67 - A67
12345